The vector of anti-Bet v1 T cell receptor (TCR) is constructed for the engineering of T cell to target Birch Bet v1. The T cells are genetically modified through transduction with a retroviral vector expressing Bet v1-specific T cell receptor. And the vector product was designed for tolerance induction therapies in individuals with allergic and other immune-mediated diseases.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|VP-TCR-C014||Lenti-Bet v1 T cell receptor Viral Particle|
|TCR-L005||Human anti-Bet v1 (TNFKYNYSVIEGGPIG) T Cell Receptor, pMMP-IRES-GFP|
|TCR-L005Z||Human anti-Bet v1 T (aa78-93) cell receptor, pCDTCR1|
|TCR-L006||Human anti-Bet v1 (TNFKYNYSVIEGGPIG) T Cell Receptor, pGMT7|
|VP-TCR-C015||Lenti-Bet v1 T cell receptor (Single-chain TCR) Viral Particle|
Copyright © 2007 - 2017 Creative Biolabs. All Rights Reserved